Literature DB >> 30150443

Peak of Standardized Uptake Value in Oral Cancer Predicts Survival Adjusting for Pathological Stage.

Hidenori Suzuki1, Tsuneo Tamaki2, Masami Nishio3, Shintaro Beppu4, Nobuaki Mukoyama5, Nobuhiro Hanai4, Daisuke Nishikawa4, Yusuke Koide4, Yasuhisa Hasegawa4.   

Abstract

BACKGROUND/AIM: To predict survival outcomes of different patients with the same stage of disease is difficult. The possible correlation between 18F-fluorodeoxyglucose (18F-FDG) uptake parameters and survival outcomes was investigated in oral squamous cell carcinoma patients by multivariate analysis adjusted for the pathological stage according to the 8th edition of the tumor-node-metastasis (TNM) classification of the Union for International Cancer Contro. PATIENTS AND METHODS: 18F-FDG-uptake parameters of 28 patients were assessed by positron emission tomography with computed tomography (PET/CT).
RESULTS: A peak of standardized uptake value of primary tumor (p-SUVpeak) of ≥14.1 was significantly correlated with shorter overall survival by univariate and multivariate analyses adjusted for the pathological TNM stage. A p-SUVpeak of ≥14.1 was significantly associated with shorter local recurrence-free survival and disease-free survival.
CONCLUSION: A higher p-SUVpeak on pretreatment 18F-FDG-PET/CT is a prognostic parameter of identifying lower survival outcomes. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  18F-FDG-PET/CT; Oral squamous cell carcinoma; SUVpeak; UICC8th; overall survival

Mesh:

Substances:

Year:  2018        PMID: 30150443      PMCID: PMC6199585          DOI: 10.21873/invivo.11363

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  15 in total

1.  Treatment evaluation of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinoma.

Authors:  Goshi Nishimura; Hideki Matsuda; Takahide Taguchi; Masahiro Takahashi; Masanori Komatsu; Daisuke Sano; Naoko Sakuma; Yasuhiro Arai; Hideaki Takahashi
Journal:  Anticancer Res       Date:  2012-02       Impact factor: 2.480

2.  Correlation between 18F-FDG-uptake and in vitro chemosensitivity of cisplatin in head and neck cancer.

Authors:  Hidenori Suzuki; Masami Nishio; Nobuhiro Hanai; Hitoshi Hirakawa; Tsuneo Tamaki; Yasuhisa Hasegawa
Journal:  Anticancer Res       Date:  2015-02       Impact factor: 2.480

3.  Update on the classification and nomenclature system for neck dissection: revisions proposed by the Japan Neck Dissection Study Group.

Authors:  Yasuhisa Hasegawa; Masahisa Saikawa
Journal:  Int J Clin Oncol       Date:  2010-01-27       Impact factor: 3.402

4.  Predictive value of metabolic tumor volume measured by 18F-FDG PET for regional lymph node status in patients with esophageal cancer.

Authors:  Ho Seok I; Seong-Jang Kim; In Joo Kim; Keunyoung Kim
Journal:  Clin Nucl Med       Date:  2012-05       Impact factor: 7.794

5.  Lymph node density predicts lung metastases in oral squamous cell carcinoma.

Authors:  H Suzuki; S Beppu; N Hanai; H Hirakawa; Y Hasegawa
Journal:  Br J Oral Maxillofac Surg       Date:  2015-12-02       Impact factor: 1.651

6.  Impact of total lesion glycolysis measured by 18F-FDG-PET/CT on overall survival and distant metastasis in hypopharyngeal cancer.

Authors:  Hidenori Suzuki; Masami Nishio; Hayao Nakanishi; Nobuhiro Hanai; Hitoshi Hirakawa; Takeshi Kodaira; Tsuneo Tamaki; Yasuhisa Hasegawa
Journal:  Oncol Lett       Date:  2016-06-23       Impact factor: 2.967

7.  Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma.

Authors:  Ronan Abgral; Nathalie Keromnes; Philippe Robin; Pierre-Yves Le Roux; David Bourhis; Xavier Palard; Jean Rousset; Gérald Valette; Rémi Marianowski; Pierre-Yves Salaün
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-07       Impact factor: 9.236

8.  The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.

Authors:  Daisuke Sano; Kenichiro Yabuki; Yasuhiro Arai; Teruhiko Tanabe; Yoshihiro Chiba; Goshi Nishimura; Hideaki Takahashi; Shoji Yamanaka; Nobuhiko Oridate
Journal:  Auris Nasus Larynx       Date:  2017-07-29       Impact factor: 1.863

9.  Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas.

Authors:  D Dequanter; M Shahla; C Aubert; Y Deniz; P Lothaire
Journal:  Onco Targets Ther       Date:  2015-08-26       Impact factor: 4.147

10.  Pathological tumor volume predicts survival outcomes in oral squamous cell carcinoma.

Authors:  Nobuaki Mukoyama; Hidenori Suzuki; Nobuhiro Hanai; Michihiko Sone; Yasuhisa Hasegawa
Journal:  Oncol Lett       Date:  2018-06-12       Impact factor: 2.967

View more
  5 in total

1.  Interaction of Interleukin-16 Genotypes With Betel Quid Chewing Behavior on Oral Cancer in Taiwan.

Authors:  Liang-Chun Shih; Wen-Shin Chang; Hsu-Tung Lee; Yun-Chi Wang; Zhi-Hong Wang; Che-Yi Chao; Chien-Chih Yu; Hui-Yi Lin; Te-Chun Shen; Chien-Chung Kuo; Chia-Wen Tsai; DA-Tian Bau
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  18F-FDG PET/CT Quantitative Parameters and Texture Analysis Effectively Differentiate Endometrial Precancerous Lesion and Early-Stage Carcinoma.

Authors:  Tong Wang; Hongzan Sun; Yan Guo; Lue Zou
Journal:  Mol Imaging       Date:  2019 Jan-Dec       Impact factor: 4.488

3.  Glycolytic pathway candidate markers in the prognosis of oral squamous cell carcinoma: a systematic review with meta-analysis.

Authors:  S E C de Mattos; L F Diel; L S Bittencourt; C E Schnorr; F A Gonçalves; L Bernardi; M L Lamers
Journal:  Braz J Med Biol Res       Date:  2021-01-25       Impact factor: 2.590

4.  Early Response Prediction of Multiparametric Functional MRI and 18F-FDG-PET in Patients with Head and Neck Squamous Cell Carcinoma Treated with (Chemo)Radiation.

Authors:  Roland M Martens; Thomas Koopman; Cristina Lavini; Tim van de Brug; Gerben J C Zwezerijnen; J Tim Marcus; Marije R Vergeer; C René Leemans; Remco de Bree; Pim de Graaf; Ronald Boellaard; Jonas A Castelijns
Journal:  Cancers (Basel)       Date:  2022-01-03       Impact factor: 6.639

5.  Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors.

Authors:  Takuma Matoba; Kiyoshi Minohara; Daisuke Kawakita; Gaku Takano; Keisuke Oguri; Akihiro Murashima; Kazuyuki Nakai; Sho Iwaki; Hiroshi Tsuge; Nobukazu Tanaka; Sae Imaizumi; Wataru Hojo; Ayano Matsumura; Koji Tsukamoto; Shinichi Esaki; Shinichi Iwasaki
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.